Cancel
Adam Dorfman
Vice President, Quality & Technical Operations
@
Clene Nanomedicine
0v06@xiu41.2hy
Sign up to see email
Known information
- Has over 13 years of experience in nanoparticle development and characterization, specimen bioanalysis, and quality control.
- Has been with Clene since 2013.
- Responsible for ensuring that the finished pharmaceuticals meet all quality standards for Clene’s active clinical trials.
- Leads the bioanalytical group that analyzes all GLP/GCP tissue and pharmacokinetic specimens collected during pre-clinical and clinical activities.
- Was originally tasked with establishing a GMP/GLP compliant lab at Clene.
- Developed and implemented Clene’s laboratory informatics system to streamline all manufacturing and quality control processes.
- Holds a BS in Chemical Engineering from The Pennsylvania State University.
- Holds an MS in Chemical and Biomolecular Engineering from Johns Hopkins University.
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
